m-PEG5-Tos is a methoxy-terminated PEG linker bearing a tosyl (tosylate) leaving group, providing a defined polyethylene glycol chain length and a single electrophilic handle for subsequent conjugation chemistry. The PEG segment confers aqueous solubility and molecular flexibility, helping PROTAC constructs maintain productive geometry between the targeting ligand and the E3 ligase-recruiting moiety while reducing nonspecific hydrophobic interactions. The tosylate enables efficient nucleophilic substitution with amines, thiols, or other suitable nucleophiles, allowing researchers to install the linker onto functional groups on PROTAC partners under standard organic synthesis conditions. In targeted protein degradation research, such PEG–tosyl linkers are widely used to tune linker length and polarity, thereby optimizing degradation potency and selectivity by modulating effective intramolecular proximity and conformational dynamics. This product is therefore a practical building block for constructing and systematically varying PROTAC architectures.
Structure of 80755-67-5
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
m-PEG5-Tos is a polyethylene glycol-based tosylate linker designed for efficient installation of PEG spacers in PROTAC architectures. Its ether-rich, flexible scaffold can improve solubility and modulate the effective distance between ligand-binding elements, supporting controlled formation of ternary complexes. The terminal tosylate provides a robust leaving group for linker conjugation, enabling streamlined synthesis of targeted protein degraders.
Structure: The linker consists of a PEG chain terminated by a tosylate (tosylate ester) group. It contains ether linkages along the PEG backbone and an aromatic sulfonate ester at the terminus. This combination yields a flexible, polar, and generally water-compatible scaffold suitable for bioconjugation workflows.
Reactivity: The terminal tosylate is primed for nucleophilic substitution, where an appropriate nucleophile (commonly an amine or phenoxide/thiolate, depending on the partner) displaces the tosylate to form a new C–N, C–O, or C–S bond. Typical conditions employ polar aprotic solvents with base to generate the nucleophile, often under mild, anhydrous handling to minimize side reactions.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.